0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Finasteride Preparations Market Research Report 2026
Published Date: 2026-02-04
|
Report Code: QYRE-Auto-1N18654
Home | Market Reports | Beauty & Fitness| Hair Care| Hair Loss
Global Finasteride Preparations Market Research Report 2024
BUY CHAPTERS

Global Finasteride Preparations Market Research Report 2026

Code: QYRE-Auto-1N18654
Report
2026-02-04
Pages:134
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Finasteride Preparations Market

The global Finasteride Preparations market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Finasteride Preparations competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Finasteride preparations refer to various formulations of finasteride, a medication primarily used in the treatment of benign prostatic hyperplasia (BPH) and male pattern hair loss (androgenetic alopecia). Available in oral tablet and capsule, finasteride is typically taken once daily, with dosage varying based on the condition being treated.
The North American market for Finasteride Preparations is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Finasteride Preparations is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
Major global manufacturers of Finasteride Preparations include Organon, Dr. Reddy's Laboratories, Teva, Aurobindo Pharma, Zydus, Hetero, Accord Healthcare, Sun Pharma, Alkem, Humanwell Pharmaceutical, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Finasteride Preparations market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Finasteride Preparations. The Finasteride Preparations market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Finasteride Preparations market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Finasteride Preparations manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Finasteride Preparations Market Report

Report Metric Details
Report Name Finasteride Preparations Market
Segment by Type
  • Capsules
  • Tablets
by Application
  • Male Pattern Baldness
  • Benign Prostatic Hyperplasia (BPH)
  • Other
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Organon, Dr. Reddy's Laboratories, Teva, Aurobindo Pharma, Zydus, Hetero, Accord Healthcare, Sun Pharma, Alkem, Humanwell Pharmaceutical, Grand Pharmaceutical, CR Double-Crane, Zhejiang Conba Pharmaceutical, Topfond Pharmaceutical, Zhejiang Xianju Pharmaceutical, Shanghai Shyndec Pharmaceutical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for Finasteride Preparations manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
  • Chapter 3: Examines Finasteride Preparations sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

Who are the main players in the Finasteride Preparations Market report?

Ans: The main players in the Finasteride Preparations Market are Organon, Dr. Reddy's Laboratories, Teva, Aurobindo Pharma, Zydus, Hetero, Accord Healthcare, Sun Pharma, Alkem, Humanwell Pharmaceutical, Grand Pharmaceutical, CR Double-Crane, Zhejiang Conba Pharmaceutical, Topfond Pharmaceutical, Zhejiang Xianju Pharmaceutical, Shanghai Shyndec Pharmaceutical

What are the Application segmentation covered in the Finasteride Preparations Market report?

Ans: The Applications covered in the Finasteride Preparations Market report are Male Pattern Baldness, Benign Prostatic Hyperplasia (BPH), Other

What are the Type segmentation covered in the Finasteride Preparations Market report?

Ans: The Types covered in the Finasteride Preparations Market report are Capsules, Tablets

1 Finasteride Preparations Market Overview
1.1 Product Definition
1.2 Finasteride Preparations by Type
1.2.1 Global Finasteride Preparations Market Value by Type: 2025 vs 2032
1.2.2 Capsules
1.2.3 Tablets
1.3 Finasteride Preparations by Application
1.3.1 Global Finasteride Preparations Market Value by Application: 2025 vs 2032
1.3.2 Male Pattern Baldness
1.3.3 Benign Prostatic Hyperplasia (BPH)
1.3.4 Other
1.4 Global Finasteride Preparations Market Size Estimates and Forecasts
1.4.1 Global Finasteride Preparations Revenue 2021–2032
1.4.2 Global Finasteride Preparations Sales 2021–2032
1.4.3 Global Finasteride Preparations Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Finasteride Preparations Market Competition by Manufacturers
2.1 Global Finasteride Preparations Sales Market Share by Manufacturers (2021–2026)
2.2 Global Finasteride Preparations Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Finasteride Preparations Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Finasteride Preparations, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Finasteride Preparations, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Finasteride Preparations, Product Types and Applications
2.7 Global Key Manufacturers of Finasteride Preparations, Date of Entry into the Industry
2.8 Global Finasteride Preparations Market Competitive Situation and Trends
2.8.1 Global Finasteride Preparations Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Finasteride Preparations Players Market Share by Revenue
2.8.3 Global Finasteride Preparations Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Finasteride Preparations Market Scenario by Region
3.1 Global Finasteride Preparations Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Finasteride Preparations Sales by Region: 2021–2032
3.2.1 Global Finasteride Preparations Sales by Region: 2021–2026
3.2.2 Global Finasteride Preparations Sales by Region: 2027–2032
3.3 Global Finasteride Preparations Revenue by Region: 2021–2032
3.3.1 Global Finasteride Preparations Revenue by Region: 2021–2026
3.3.2 Global Finasteride Preparations Revenue by Region: 2027–2032
3.4 North America Finasteride Preparations Market Facts & Figures by Country
3.4.1 North America Finasteride Preparations Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Finasteride Preparations Sales by Country (2021–2032)
3.4.3 North America Finasteride Preparations Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Finasteride Preparations Market Facts & Figures by Country
3.5.1 Europe Finasteride Preparations Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Finasteride Preparations Sales by Country (2021–2032)
3.5.3 Europe Finasteride Preparations Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Finasteride Preparations Market Facts & Figures by Region
3.6.1 Asia Pacific Finasteride Preparations Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Finasteride Preparations Sales by Region (2021–2032)
3.6.3 Asia Pacific Finasteride Preparations Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Finasteride Preparations Market Facts & Figures by Country
3.7.1 Latin America Finasteride Preparations Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Finasteride Preparations Sales by Country (2021–2032)
3.7.3 Latin America Finasteride Preparations Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Finasteride Preparations Market Facts & Figures by Country
3.8.1 Middle East and Africa Finasteride Preparations Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Finasteride Preparations Sales by Country (2021–2032)
3.8.3 Middle East and Africa Finasteride Preparations Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Finasteride Preparations Sales by Type (2021–2032)
4.1.1 Global Finasteride Preparations Sales by Type (2021–2026)
4.1.2 Global Finasteride Preparations Sales by Type (2027–2032)
4.1.3 Global Finasteride Preparations Sales Market Share by Type (2021–2032)
4.2 Global Finasteride Preparations Revenue by Type (2021–2032)
4.2.1 Global Finasteride Preparations Revenue by Type (2021–2026)
4.2.2 Global Finasteride Preparations Revenue by Type (2027–2032)
4.2.3 Global Finasteride Preparations Revenue Market Share by Type (2021–2032)
4.3 Global Finasteride Preparations Price by Type (2021–2032)
5 Segment by Application
5.1 Global Finasteride Preparations Sales by Application (2021–2032)
5.1.1 Global Finasteride Preparations Sales by Application (2021–2026)
5.1.2 Global Finasteride Preparations Sales by Application (2027–2032)
5.1.3 Global Finasteride Preparations Sales Market Share by Application (2021–2032)
5.2 Global Finasteride Preparations Revenue by Application (2021–2032)
5.2.1 Global Finasteride Preparations Revenue by Application (2021–2026)
5.2.2 Global Finasteride Preparations Revenue by Application (2027–2032)
5.2.3 Global Finasteride Preparations Revenue Market Share by Application (2021–2032)
5.3 Global Finasteride Preparations Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Organon
6.1.1 Organon Company Information
6.1.2 Organon Description and Business Overview
6.1.3 Organon Finasteride Preparations Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Organon Finasteride Preparations Product Portfolio
6.1.5 Organon Recent Developments/Updates
6.2 Dr. Reddy's Laboratories
6.2.1 Dr. Reddy's Laboratories Company Information
6.2.2 Dr. Reddy's Laboratories Description and Business Overview
6.2.3 Dr. Reddy's Laboratories Finasteride Preparations Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Dr. Reddy's Laboratories Finasteride Preparations Product Portfolio
6.2.5 Dr. Reddy's Laboratories Recent Developments/Updates
6.3 Teva
6.3.1 Teva Company Information
6.3.2 Teva Description and Business Overview
6.3.3 Teva Finasteride Preparations Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Teva Finasteride Preparations Product Portfolio
6.3.5 Teva Recent Developments/Updates
6.4 Aurobindo Pharma
6.4.1 Aurobindo Pharma Company Information
6.4.2 Aurobindo Pharma Description and Business Overview
6.4.3 Aurobindo Pharma Finasteride Preparations Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Aurobindo Pharma Finasteride Preparations Product Portfolio
6.4.5 Aurobindo Pharma Recent Developments/Updates
6.5 Zydus
6.5.1 Zydus Company Information
6.5.2 Zydus Description and Business Overview
6.5.3 Zydus Finasteride Preparations Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Zydus Finasteride Preparations Product Portfolio
6.5.5 Zydus Recent Developments/Updates
6.6 Hetero
6.6.1 Hetero Company Information
6.6.2 Hetero Description and Business Overview
6.6.3 Hetero Finasteride Preparations Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Hetero Finasteride Preparations Product Portfolio
6.6.5 Hetero Recent Developments/Updates
6.7 Accord Healthcare
6.7.1 Accord Healthcare Company Information
6.7.2 Accord Healthcare Description and Business Overview
6.7.3 Accord Healthcare Finasteride Preparations Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Accord Healthcare Finasteride Preparations Product Portfolio
6.7.5 Accord Healthcare Recent Developments/Updates
6.8 Sun Pharma
6.8.1 Sun Pharma Company Information
6.8.2 Sun Pharma Description and Business Overview
6.8.3 Sun Pharma Finasteride Preparations Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Sun Pharma Finasteride Preparations Product Portfolio
6.8.5 Sun Pharma Recent Developments/Updates
6.9 Alkem
6.9.1 Alkem Company Information
6.9.2 Alkem Description and Business Overview
6.9.3 Alkem Finasteride Preparations Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Alkem Finasteride Preparations Product Portfolio
6.9.5 Alkem Recent Developments/Updates
6.10 Humanwell Pharmaceutical
6.10.1 Humanwell Pharmaceutical Company Information
6.10.2 Humanwell Pharmaceutical Description and Business Overview
6.10.3 Humanwell Pharmaceutical Finasteride Preparations Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Humanwell Pharmaceutical Finasteride Preparations Product Portfolio
6.10.5 Humanwell Pharmaceutical Recent Developments/Updates
6.11 Grand Pharmaceutical
6.11.1 Grand Pharmaceutical Company Information
6.11.2 Grand Pharmaceutical Description and Business Overview
6.11.3 Grand Pharmaceutical Finasteride Preparations Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Grand Pharmaceutical Finasteride Preparations Product Portfolio
6.11.5 Grand Pharmaceutical Recent Developments/Updates
6.12 CR Double-Crane
6.12.1 CR Double-Crane Company Information
6.12.2 CR Double-Crane Description and Business Overview
6.12.3 CR Double-Crane Finasteride Preparations Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 CR Double-Crane Finasteride Preparations Product Portfolio
6.12.5 CR Double-Crane Recent Developments/Updates
6.13 Zhejiang Conba Pharmaceutical
6.13.1 Zhejiang Conba Pharmaceutical Company Information
6.13.2 Zhejiang Conba Pharmaceutical Description and Business Overview
6.13.3 Zhejiang Conba Pharmaceutical Finasteride Preparations Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 Zhejiang Conba Pharmaceutical Finasteride Preparations Product Portfolio
6.13.5 Zhejiang Conba Pharmaceutical Recent Developments/Updates
6.14 Topfond Pharmaceutical
6.14.1 Topfond Pharmaceutical Company Information
6.14.2 Topfond Pharmaceutical Description and Business Overview
6.14.3 Topfond Pharmaceutical Finasteride Preparations Sales, Revenue, and Gross Margin (2021–2026)
6.14.4 Topfond Pharmaceutical Finasteride Preparations Product Portfolio
6.14.5 Topfond Pharmaceutical Recent Developments/Updates
6.15 Zhejiang Xianju Pharmaceutical
6.15.1 Zhejiang Xianju Pharmaceutical Company Information
6.15.2 Zhejiang Xianju Pharmaceutical Description and Business Overview
6.15.3 Zhejiang Xianju Pharmaceutical Finasteride Preparations Sales, Revenue, and Gross Margin (2021–2026)
6.15.4 Zhejiang Xianju Pharmaceutical Finasteride Preparations Product Portfolio
6.15.5 Zhejiang Xianju Pharmaceutical Recent Developments/Updates
6.16 Shanghai Shyndec Pharmaceutical
6.16.1 Shanghai Shyndec Pharmaceutical Company Information
6.16.2 Shanghai Shyndec Pharmaceutical Description and Business Overview
6.16.3 Shanghai Shyndec Pharmaceutical Finasteride Preparations Sales, Revenue, and Gross Margin (2021–2026)
6.16.4 Shanghai Shyndec Pharmaceutical Finasteride Preparations Product Portfolio
6.16.5 Shanghai Shyndec Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Finasteride Preparations Industry Chain Analysis
7.2 Finasteride Preparations Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Finasteride Preparations Production Mode & Process Analysis
7.4 Finasteride Preparations Sales and Marketing
7.4.1 Finasteride Preparations Sales Channels
7.4.2 Finasteride Preparations Distributors
7.5 Finasteride Preparations Customer Analysis
8 Finasteride Preparations Market Dynamics
8.1 Finasteride Preparations Industry Trends
8.2 Finasteride Preparations Market Drivers
8.3 Finasteride Preparations Market Challenges
8.4 Finasteride Preparations Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Finasteride Preparations Market Value by Type (US$ Million), 2025 vs 2032
 Table 2. Global Finasteride Preparations Market Value by Application (US$ Million), 2025 vs 2032
 Table 3. Global Finasteride Preparations Market Competitive Situation by Manufacturers in 2025
 Table 4. Global Finasteride Preparations Sales (K Units) of Key Manufacturers (2021–2026)
 Table 5. Global Finasteride Preparations Sales Market Share by Manufacturers (2021–2026)
 Table 6. Global Finasteride Preparations Revenue (US$ Million) by Manufacturers (2021–2026)
 Table 7. Global Finasteride Preparations Revenue Share by Manufacturers (2021–2026)
 Table 8. Global Market Finasteride Preparations Average Price (US$/Unit) of Key Manufacturers (2021–2026)
 Table 9. Global Key Players of Finasteride Preparations, Industry Ranking, 2023 vs 2024 vs 2025
 Table 10. Global Key Manufacturers of Finasteride Preparations, Manufacturing Sites and Headquarters
 Table 11. Global Key Manufacturers of Finasteride Preparations, Product Types and Applications
 Table 12. Global Key Manufacturers of Finasteride Preparations, Date of Entry into the Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Finasteride Preparations Companies by Tier (Tier 1, Tier 2, Tier 3), based on Finasteride Preparations Revenue, 2025
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Finasteride Preparations Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 17. Global Finasteride Preparations Sales by Region (K Units), 2021–2026
 Table 18. Global Finasteride Preparations Sales Market Share by Region (2021–2026)
 Table 19. Global Finasteride Preparations Sales by Region (K Units), 2027–2032
 Table 20. Global Finasteride Preparations Sales Market Share by Region (2027–2032)
 Table 21. Global Finasteride Preparations Revenue by Region (US$ Million), 2021–2026
 Table 22. Global Finasteride Preparations Revenue Market Share by Region (2021–2026)
 Table 23. Global Finasteride Preparations Revenue by Region (US$ Million), 2027–2032
 Table 24. Global Finasteride Preparations Revenue Market Share by Region (2027–2032)
 Table 25. North America Finasteride Preparations Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 26. North America Finasteride Preparations Sales by Country (K Units), 2021–2026
 Table 27. North America Finasteride Preparations Sales by Country (K Units), 2027–2032
 Table 28. North America Finasteride Preparations Revenue by Country (US$ Million), 2021–2026
 Table 29. North America Finasteride Preparations Revenue by Country (US$ Million), 2027–2032
 Table 30. Europe Finasteride Preparations Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 31. Europe Finasteride Preparations Sales by Country (K Units), 2021–2026
 Table 32. Europe Finasteride Preparations Sales by Country (K Units), 2027–2032
 Table 33. Europe Finasteride Preparations Revenue by Country (US$ Million), 2021–2026
 Table 34. Europe Finasteride Preparations Revenue by Country (US$ Million), 2027–2032
 Table 35. Asia Pacific Finasteride Preparations Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 36. Asia Pacific Finasteride Preparations Sales by Region (K Units), 2021–2026
 Table 37. Asia Pacific Finasteride Preparations Sales by Region (K Units), 2027–2032
 Table 38. Asia Pacific Finasteride Preparations Revenue by Region (US$ Million), 2021–2026
 Table 39. Asia Pacific Finasteride Preparations Revenue by Region (US$ Million), 2027–2032
 Table 40. Latin America Finasteride Preparations Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 41. Latin America Finasteride Preparations Sales by Country (K Units), 2021–2026
 Table 42. Latin America Finasteride Preparations Sales by Country (K Units), 2027–2032
 Table 43. Latin America Finasteride Preparations Revenue by Country (US$ Million), 2021–2026
 Table 44. Latin America Finasteride Preparations Revenue by Country (US$ Million), 2027–2032
 Table 45. Middle East and Africa Finasteride Preparations Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 46. Middle East and Africa Finasteride Preparations Sales by Country (K Units), 2021–2026
 Table 47. Middle East and Africa Finasteride Preparations Sales by Country (K Units), 2027–2032
 Table 48. Middle East and Africa Finasteride Preparations Revenue by Country (US$ Million), 2021–2026
 Table 49. Middle East and Africa Finasteride Preparations Revenue by Country (US$ Million), 2027–2032
 Table 50. Global Finasteride Preparations Sales (K Units) by Type (2021–2026)
 Table 51. Global Finasteride Preparations Sales (K Units) by Type (2027–2032)
 Table 52. Global Finasteride Preparations Sales Market Share by Type (2021–2026)
 Table 53. Global Finasteride Preparations Sales Market Share by Type (2027–2032)
 Table 54. Global Finasteride Preparations Revenue (US$ Million) by Type (2021–2026)
 Table 55. Global Finasteride Preparations Revenue (US$ Million) by Type (2027–2032)
 Table 56. Global Finasteride Preparations Revenue Market Share by Type (2021–2026)
 Table 57. Global Finasteride Preparations Revenue Market Share by Type (2027–2032)
 Table 58. Global Finasteride Preparations Price (US$/Unit) by Type (2021–2026)
 Table 59. Global Finasteride Preparations Price (US$/Unit) by Type (2027–2032)
 Table 60. Global Finasteride Preparations Sales (K Units) by Application (2021–2026)
 Table 61. Global Finasteride Preparations Sales (K Units) by Application (2027–2032)
 Table 62. Global Finasteride Preparations Sales Market Share by Application (2021–2026)
 Table 63. Global Finasteride Preparations Sales Market Share by Application (2027–2032)
 Table 64. Global Finasteride Preparations Revenue (US$ Million) by Application (2021–2026)
 Table 65. Global Finasteride Preparations Revenue (US$ Million) by Application (2027–2032)
 Table 66. Global Finasteride Preparations Revenue Market Share by Application (2021–2026)
 Table 67. Global Finasteride Preparations Revenue Market Share by Application (2027–2032)
 Table 68. Global Finasteride Preparations Price (US$/Unit) by Application (2021–2026)
 Table 69. Global Finasteride Preparations Price (US$/Unit) by Application (2027–2032)
 Table 70. Organon Company Information
 Table 71. Organon Description and Business Overview
 Table 72. Organon Finasteride Preparations Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 73. Organon Finasteride Preparations Product
 Table 74. Organon Recent Developments/Updates
 Table 75. Dr. Reddy's Laboratories Company Information
 Table 76. Dr. Reddy's Laboratories Description and Business Overview
 Table 77. Dr. Reddy's Laboratories Finasteride Preparations Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 78. Dr. Reddy's Laboratories Finasteride Preparations Product
 Table 79. Dr. Reddy's Laboratories Recent Developments/Updates
 Table 80. Teva Company Information
 Table 81. Teva Description and Business Overview
 Table 82. Teva Finasteride Preparations Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 83. Teva Finasteride Preparations Product
 Table 84. Teva Recent Developments/Updates
 Table 85. Aurobindo Pharma Company Information
 Table 86. Aurobindo Pharma Description and Business Overview
 Table 87. Aurobindo Pharma Finasteride Preparations Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 88. Aurobindo Pharma Finasteride Preparations Product
 Table 89. Aurobindo Pharma Recent Developments/Updates
 Table 90. Zydus Company Information
 Table 91. Zydus Description and Business Overview
 Table 92. Zydus Finasteride Preparations Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 93. Zydus Finasteride Preparations Product
 Table 94. Zydus Recent Developments/Updates
 Table 95. Hetero Company Information
 Table 96. Hetero Description and Business Overview
 Table 97. Hetero Finasteride Preparations Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 98. Hetero Finasteride Preparations Product
 Table 99. Hetero Recent Developments/Updates
 Table 100. Accord Healthcare Company Information
 Table 101. Accord Healthcare Description and Business Overview
 Table 102. Accord Healthcare Finasteride Preparations Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 103. Accord Healthcare Finasteride Preparations Product
 Table 104. Accord Healthcare Recent Developments/Updates
 Table 105. Sun Pharma Company Information
 Table 106. Sun Pharma Description and Business Overview
 Table 107. Sun Pharma Finasteride Preparations Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 108. Sun Pharma Finasteride Preparations Product
 Table 109. Sun Pharma Recent Developments/Updates
 Table 110. Alkem Company Information
 Table 111. Alkem Description and Business Overview
 Table 112. Alkem Finasteride Preparations Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 113. Alkem Finasteride Preparations Product
 Table 114. Alkem Recent Developments/Updates
 Table 115. Humanwell Pharmaceutical Company Information
 Table 116. Humanwell Pharmaceutical Description and Business Overview
 Table 117. Humanwell Pharmaceutical Finasteride Preparations Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 118. Humanwell Pharmaceutical Finasteride Preparations Product
 Table 119. Humanwell Pharmaceutical Recent Developments/Updates
 Table 120. Grand Pharmaceutical Company Information
 Table 121. Grand Pharmaceutical Description and Business Overview
 Table 122. Grand Pharmaceutical Finasteride Preparations Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 123. Grand Pharmaceutical Finasteride Preparations Product
 Table 124. Grand Pharmaceutical Recent Developments/Updates
 Table 125. CR Double-Crane Company Information
 Table 126. CR Double-Crane Description and Business Overview
 Table 127. CR Double-Crane Finasteride Preparations Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 128. CR Double-Crane Finasteride Preparations Product
 Table 129. CR Double-Crane Recent Developments/Updates
 Table 130. Zhejiang Conba Pharmaceutical Company Information
 Table 131. Zhejiang Conba Pharmaceutical Description and Business Overview
 Table 132. Zhejiang Conba Pharmaceutical Finasteride Preparations Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 133. Zhejiang Conba Pharmaceutical Finasteride Preparations Product
 Table 134. Zhejiang Conba Pharmaceutical Recent Developments/Updates
 Table 135. Topfond Pharmaceutical Company Information
 Table 136. Topfond Pharmaceutical Description and Business Overview
 Table 137. Topfond Pharmaceutical Finasteride Preparations Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 138. Topfond Pharmaceutical Finasteride Preparations Product
 Table 139. Topfond Pharmaceutical Recent Developments/Updates
 Table 140. Zhejiang Xianju Pharmaceutical Company Information
 Table 141. Zhejiang Xianju Pharmaceutical Description and Business Overview
 Table 142. Zhejiang Xianju Pharmaceutical Finasteride Preparations Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 143. Zhejiang Xianju Pharmaceutical Finasteride Preparations Product
 Table 144. Zhejiang Xianju Pharmaceutical Recent Developments/Updates
 Table 145. Shanghai Shyndec Pharmaceutical Company Information
 Table 146. Shanghai Shyndec Pharmaceutical Description and Business Overview
 Table 147. Shanghai Shyndec Pharmaceutical Finasteride Preparations Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 148. Shanghai Shyndec Pharmaceutical Finasteride Preparations Product
 Table 149. Shanghai Shyndec Pharmaceutical Recent Developments/Updates
 Table 150. Key Raw Materials Lists
 Table 151. Raw Materials Key Suppliers Lists
 Table 152. Finasteride Preparations Distributors List
 Table 153. Finasteride Preparations Customers List
 Table 154. Finasteride Preparations Market Trends
 Table 155. Finasteride Preparations Market Drivers
 Table 156. Finasteride Preparations Market Challenges
 Table 157. Finasteride Preparations Market Restraints
 Table 158. Research Programs/Design for This Report
 Table 159. Key Data Information from Secondary Sources
 Table 160. Key Data Information from Primary Sources
 Table 161. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Finasteride Preparations
 Figure 2. Global Finasteride Preparations Market Value by Type (US$ Million), 2021–2032
 Figure 3. Global Finasteride Preparations Market Share by Type: 2025 & 2032
 Figure 4. Capsules Product Picture
 Figure 5. Tablets Product Picture
 Figure 6. Global Finasteride Preparations Market Value by Application (US$ Million), 2021–2032
 Figure 7. Global Finasteride Preparations Market Share by Application: 2025 & 2032
 Figure 8. Male Pattern Baldness
 Figure 9. Benign Prostatic Hyperplasia (BPH)
 Figure 10. Other
 Figure 11. Global Finasteride Preparations Revenue, (US$ Million), 2021 vs 2025 vs 2032
 Figure 12. Global Finasteride Preparations Market Size (US$ Million), 2021–2032
 Figure 13. Global Finasteride Preparations Sales (K Units), 2021–2032
 Figure 14. Global Finasteride Preparations Average Price (US$/Unit), 2021–2032
 Figure 15. Finasteride Preparations Report Years Considered
 Figure 16. Finasteride Preparations Sales Share by Manufacturers in 2025
 Figure 17. Global Finasteride Preparations Revenue Share by Manufacturers in 2025
 Figure 18. Top 5 and Top 10 Global Finasteride Preparations Players: Market Share by Revenue in Finasteride Preparations in 2025
 Figure 19. Finasteride Preparations Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 20. Global Finasteride Preparations Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Figure 21. North America Finasteride Preparations Sales Market Share by Country (2021–2032)
 Figure 22. North America Finasteride Preparations Revenue Market Share by Country (2021–2032)
 Figure 23. United States Finasteride Preparations Revenue Growth Rate (US$ Million), 2021–2032
 Figure 24. Canada Finasteride Preparations Revenue Growth Rate (US$ Million), 2021–2032
 Figure 25. Europe Finasteride Preparations Sales Market Share by Country (2021–2032)
 Figure 26. Europe Finasteride Preparations Revenue Market Share by Country (2021–2032)
 Figure 27. Germany Finasteride Preparations Revenue Growth Rate (US$ Million), 2021–2032
 Figure 28. France Finasteride Preparations Revenue Growth Rate (US$ Million), 2021–2032
 Figure 29. U.K. Finasteride Preparations Revenue Growth Rate (US$ Million), 2021–2032
 Figure 30. Italy Finasteride Preparations Revenue Growth Rate (US$ Million), 2021–2032
 Figure 31. Russia Finasteride Preparations Revenue Growth Rate (US$ Million), 2021–2032
 Figure 32. Asia Pacific Finasteride Preparations Sales Market Share by Region (2021–2032)
 Figure 33. Asia Pacific Finasteride Preparations Revenue Market Share by Region (2021–2032)
 Figure 34. China Finasteride Preparations Revenue Growth Rate (US$ Million), 2021–2032
 Figure 35. Japan Finasteride Preparations Revenue Growth Rate (US$ Million), 2021–2032
 Figure 36. South Korea Finasteride Preparations Revenue Growth Rate (US$ Million), 2021–2032
 Figure 37. India Finasteride Preparations Revenue Growth Rate (US$ Million), 2021–2032
 Figure 38. Australia Finasteride Preparations Revenue Growth Rate (US$ Million), 2021–2032
 Figure 39. China Taiwan Finasteride Preparations Revenue Growth Rate (US$ Million), 2021–2032
 Figure 40. Southeast Asia Finasteride Preparations Revenue Growth Rate (US$ Million), 2021–2032
 Figure 41. Latin America Finasteride Preparations Sales Market Share by Country (2021–2032)
 Figure 42. Latin America Finasteride Preparations Revenue Market Share by Country (2021–2032)
 Figure 43. Mexico Finasteride Preparations Revenue Growth Rate (US$ Million), 2021–2032
 Figure 44. Brazil Finasteride Preparations Revenue Growth Rate (US$ Million), 2021–2032
 Figure 45. Argentina Finasteride Preparations Revenue Growth Rate (US$ Million), 2021–2032
 Figure 46. Colombia Finasteride Preparations Revenue Growth Rate (US$ Million), 2021–2032
 Figure 47. Middle East and Africa Finasteride Preparations Sales Market Share by Country (2021–2032)
 Figure 48. Middle East and Africa Finasteride Preparations Revenue Market Share by Country (2021–2032)
 Figure 49. Turkey Finasteride Preparations Revenue Growth Rate (US$ Million), 2021–2032
 Figure 50. Saudi Arabia Finasteride Preparations Revenue Growth Rate (US$ Million), 2021–2032
 Figure 51. UAE Finasteride Preparations Revenue Growth Rate (US$ Million), 2021–2032
 Figure 52. Global Sales Market Share of Finasteride Preparations by Type (2021–2032)
 Figure 53. Global Revenue Market Share of Finasteride Preparations by Type (2021–2032)
 Figure 54. Global Finasteride Preparations Price (US$/Unit) by Type (2021–2032)
 Figure 55. Global Sales Market Share of Finasteride Preparations by Application (2021–2032)
 Figure 56. Global Revenue Market Share of Finasteride Preparations by Application (2021–2032)
 Figure 57. Global Finasteride Preparations Price (US$/Unit) by Application (2021–2032)
 Figure 58. Finasteride Preparations Value Chain
 Figure 59. Channels of Distribution (Direct Vs Distribution)
 Figure 60. Bottom-up and Top-down Approaches for This Report
 Figure 61. Data Triangulation
 Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Lukasiewicz Research Network